BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Bannaga A, Arasaradnam RP. Neutrophil to lymphocyte ratio and albumin bilirubin grade in hepatocellular carcinoma: A systematic review. World J Gastroenterol 2020; 26(33): 5022-5049 [PMID: 32952347 DOI: 10.3748/wjg.v26.i33.5022]
URL: https://www.wjgnet.com/1007-9327/full/v26/i33/5022.htm
Number Citing Articles
1
Linh Pham, Konstantina Kyritsi, Tianhao Zhou, Ludovica Ceci, Leonardo Baiocchi, Lindsey Kennedy, Sanjukta Chakraborty, Shannon Glaser, Heather Francis, Gianfranco Alpini, Keisaku Sato. The Functional Roles of Immune Cells in Primary Liver CancerThe American Journal of Pathology 2022; 192(6): 826 doi: 10.1016/j.ajpath.2022.02.004
2
Xiaowei Chi, Liejun Jiang, Yulin Yuan, Xinyan Huang, Xuemei Yang, Steven Hochwald, Jie Liu, Huayi Huang. A comparison of clinical pathologic characteristics between alpha-fetoprotein negative and positive hepatocellular carcinoma patients from Eastern and Southern ChinaBMC Gastroenterology 2022; 22(1) doi: 10.1186/s12876-022-02279-w
3
Brian I. Carr, Harika Gozukara Bag, Volkan Ince, Sami Akbulut, Veysel Ersan, Sertac Usta, Burak Isik, Zeki Ogut, Adem Tuncer, Sezai Yilmaz. A Combination of Blood Lymphocytes and AST Levels Distinguishes Patients with Small Hepatocellular Carcinomas from Non-cancer PatientsJournal of Gastrointestinal Cancer 2021; 52(4): 1211 doi: 10.1007/s12029-021-00740-9
4
Zhen Qu, Yun-jie Lu, Jia-Wei Feng, Yu-xiang Chen, Long-qing Shi, Jing Chen, Navin Rambaran, Yun-Fei Duan, Xiao-zhou He. Preoperative Prognostic Nutritional Index and Neutrophil-to-Lymphocyte Ratio Predict Survival Outcomes of Patients With Hepatocellular Carcinoma After Curative ResectionFrontiers in Oncology 2022; 11 doi: 10.3389/fonc.2021.823054
5
Jing-Houng Wang, Yen-Yang Chen, Kwong-Ming Kee, Chih-Chi Wang, Ming-Chao Tsai, Yuan-Hung Kuo, Chao-Hung Hung, Wei-Feng Li, Hsiang-Lan Lai, Yen-Hao Chen. The Prognostic Value of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Patients with Hepatocellular Carcinoma Receiving Atezolizumab Plus BevacizumabCancers 2022; 14(2): 343 doi: 10.3390/cancers14020343
6
Hee Ho Chu, Jin Hyoung Kim, Ju Hyun Shim, Dong Il Gwon, Heung-Kyu Ko, Ji Hoon Shin, Gi-Young Ko, Hyun-Ki Yoon, Nayoung Kim. Neutrophil-to-Lymphocyte Ratio as a Biomarker Predicting Overall Survival after Chemoembolization for Intermediate-Stage Hepatocellular CarcinomaCancers 2021; 13(11): 2830 doi: 10.3390/cancers13112830
7
Ayman S. Bannaga, Rocio Alvarez, Lisa Zhou, Michael Petchey, Angela Noufaily, Megan P. Hitchins, Ramesh P. Arasaradnam. Role of methylated septin 9 as an adjunct diagnostic and prognostic biomarker in hepatocellular carcinomaHPB 2021; 23(10): 1595 doi: 10.1016/j.hpb.2021.03.015